(Q35134612)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763517%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

review article

1 reference

title

Hormone replacement therapy and endometrial, ovarian and colorectal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763517%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

Hormone Replacement Therapy

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763517%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

Gambacciani M

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763517%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Sacco A

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763517%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Genazzani AR

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763517%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763517%20AND%20SRC:MED&resulttype=core&format=json

Best Practice and Research: Clinical Endocrinology and Metabolism

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763517%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763517%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763517%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

139-147

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763517%20AND%20SRC:MED&resulttype=core&format=json

Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

Risk of Localized and Widespread Endometrial Cancer in Relation to Recent and Discontinued Use of Conjugated Estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

Risk of endometrial cancer in relation to use of low-dose, unopposed estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

Endometrial hyperplasia in women on cyclic or continuous estrogen regimens

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

Pharmacokinetic and pharmacologic variation between different estrogen products

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: chemistry and metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

The effects of oral estriol on the endometrium in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

Low-potency oestrogen and risk of endometrial cancer: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

Estrogen-progestin replacement therapy and endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

Adverse endometrial effects during long cycle hormone replacement therapy. Scandinavian Long Cycle Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

Risk of Endometrial Cancer Following Estrogen Replacement With and Without Progestins

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

Hormone replacement therapy and endometrial cancer risk: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

1 reference

7 January 2021

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

Use of oral contraceptives and endometrial cancer risk (Sweden)

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

Oestrogen replacement treatment and the risk of endometrial cancer: an assessment of the role of covariates

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

Estrogen replacement therapy following treatment for stage I endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

Estrogen replacement in surgical stage I and II endometrial cancer survivors

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

Estrogen replacement therapy in endometrial cancer patients: a matched control study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

Lifestyle and colon cancer: an assessment of factors associated with risk

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

Vitamin E and colon cancer: is there an association?

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

Exogenous hormones, reproductive history, and colon cancer (Seattle, Washington, USA)

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

Reproductive factors and colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

The influence of reproductive and hormonal factors on the risk of colon and rectal cancer in women

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

Postmenopausal hormone use and risk of large-bowel cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

Postmenopausal hormone use and risk for colorectal cancer and adenoma

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

Hormone replacement therapy and improved survival among postmenopausal women diagnosed with colon cancer (USA).

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

Epidemiology of ovarian cancer: a summary review

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

Hormonal therapy for menopause and ovarian cancer in a collaborative re-analysis of European studies

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

Menopausal hormone replacement therapy and risk of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900086-6

7 January 2021

10.1016/S1521-690X(02)00086-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12763517%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference